A Powerful Investment Alliance of Aztiq and Innobic Acquires Alvogen's Shares in Lotus and Adalvo in a US$475m Deal
The Consortium jointly, through Aztiq II HoldCo, will acquire a 100% stake in Alvogen Emerging Markets Holdings Limited, thereby becoming the leading shareholders in Lotus Pharmaceuticals and Adalvo
Source: finanznachrichten.de